nodes	percent_of_prediction	percent_of_DWPC	metapath
Goserelin—Reaction aggravation—Carmustine—malignant glioma	0.0588	0.0822	CcSEcCtD
Goserelin—Adverse reaction—Carmustine—malignant glioma	0.0588	0.0822	CcSEcCtD
Goserelin—Icatibant—BDKRB2—malignant glioma	0.0422	0.878	CrCbGaD
Goserelin—Condition aggravated—Temozolomide—malignant glioma	0.0326	0.0456	CcSEcCtD
Goserelin—Cerebral ischaemia—Temozolomide—malignant glioma	0.0123	0.0172	CcSEcCtD
Goserelin—Transient ischaemic attack—Temozolomide—malignant glioma	0.0118	0.0165	CcSEcCtD
Goserelin—LHCGR—Ovarian Infertility Genes—NCOR1—malignant glioma	0.0114	0.0483	CbGpPWpGaD
Goserelin—LHCGR—Peptide GPCRs—CCR4—malignant glioma	0.0113	0.0479	CbGpPWpGaD
Goserelin—Febrile neutropenia—Carmustine—malignant glioma	0.0103	0.0143	CcSEcCtD
Goserelin—Febrile neutropenia—Temozolomide—malignant glioma	0.00991	0.0138	CcSEcCtD
Goserelin—Deep vein thrombosis—Temozolomide—malignant glioma	0.0098	0.0137	CcSEcCtD
Goserelin—Cyst—Carmustine—malignant glioma	0.00923	0.0129	CcSEcCtD
Goserelin—LHCGR—Peptide GPCRs—CXCR3—malignant glioma	0.0084	0.0356	CbGpPWpGaD
Goserelin—LHCGR—Arf6 signaling events—MET—malignant glioma	0.00836	0.0354	CbGpPWpGaD
Goserelin—Vaginal haemorrhage—Temozolomide—malignant glioma	0.00806	0.0113	CcSEcCtD
Goserelin—Menorrhagia—Temozolomide—malignant glioma	0.00806	0.0113	CcSEcCtD
Goserelin—Herpes zoster—Temozolomide—malignant glioma	0.00792	0.0111	CcSEcCtD
Goserelin—LHCGR—Arf6 signaling events—EGF—malignant glioma	0.00778	0.033	CbGpPWpGaD
Goserelin—LHCGR—Peptide GPCRs—BDKRB2—malignant glioma	0.00769	0.0326	CbGpPWpGaD
Goserelin—GNRHR—Peptide GPCRs—CCR4—malignant glioma	0.00757	0.0321	CbGpPWpGaD
Goserelin—Endocrine disorder—Temozolomide—malignant glioma	0.00719	0.01	CcSEcCtD
Goserelin—Extravasation—Carmustine—malignant glioma	0.00707	0.00988	CcSEcCtD
Goserelin—Breast pain—Temozolomide—malignant glioma	0.00683	0.00955	CcSEcCtD
Goserelin—Amenorrhoea—Temozolomide—malignant glioma	0.00679	0.00948	CcSEcCtD
Goserelin—Thinking abnormal—Carmustine—malignant glioma	0.00674	0.00941	CcSEcCtD
Goserelin—Herpes simplex—Temozolomide—malignant glioma	0.00647	0.00904	CcSEcCtD
Goserelin—Pulmonary embolism—Carmustine—malignant glioma	0.00617	0.00862	CcSEcCtD
Goserelin—Injection site reaction—Carmustine—malignant glioma	0.00613	0.00857	CcSEcCtD
Goserelin—Pulmonary embolism—Temozolomide—malignant glioma	0.00596	0.00833	CcSEcCtD
Goserelin—Vaginal inflammation—Temozolomide—malignant glioma	0.00596	0.00833	CcSEcCtD
Goserelin—Urinary incontinence—Carmustine—malignant glioma	0.00596	0.00832	CcSEcCtD
Goserelin—Pentagastrin—BCHE—malignant glioma	0.00585	0.122	CrCbGaD
Goserelin—Urinary incontinence—Temozolomide—malignant glioma	0.00576	0.00804	CcSEcCtD
Goserelin—Vaginal infection—Temozolomide—malignant glioma	0.00563	0.00786	CcSEcCtD
Goserelin—GNRHR—Peptide GPCRs—CXCR3—malignant glioma	0.00563	0.0238	CbGpPWpGaD
Goserelin—Neoplasm—Carmustine—malignant glioma	0.00558	0.00779	CcSEcCtD
Goserelin—Gynaecomastia—Carmustine—malignant glioma	0.00552	0.00771	CcSEcCtD
Goserelin—Dry eye—Temozolomide—malignant glioma	0.00551	0.00769	CcSEcCtD
Goserelin—Neoplasm—Temozolomide—malignant glioma	0.00539	0.00753	CcSEcCtD
Goserelin—Mental disability—Carmustine—malignant glioma	0.00535	0.00748	CcSEcCtD
Goserelin—Sepsis—Carmustine—malignant glioma	0.00535	0.00748	CcSEcCtD
Goserelin—Mental disability—Temozolomide—malignant glioma	0.00517	0.00723	CcSEcCtD
Goserelin—Thrombophlebitis—Carmustine—malignant glioma	0.00517	0.00723	CcSEcCtD
Goserelin—Diabetes mellitus—Carmustine—malignant glioma	0.00515	0.00719	CcSEcCtD
Goserelin—GNRHR—Peptide GPCRs—BDKRB2—malignant glioma	0.00515	0.0218	CbGpPWpGaD
Goserelin—Swelling—Carmustine—malignant glioma	0.00508	0.00709	CcSEcCtD
Goserelin—Thrombophlebitis—Temozolomide—malignant glioma	0.005	0.00698	CcSEcCtD
Goserelin—GNRHR—GPCRs, Other—CXCR3—malignant glioma	0.00477	0.0202	CbGpPWpGaD
Goserelin—Amnesia—Carmustine—malignant glioma	0.00477	0.00666	CcSEcCtD
Goserelin—Hot flush—Temozolomide—malignant glioma	0.00463	0.00646	CcSEcCtD
Goserelin—Amnesia—Temozolomide—malignant glioma	0.00461	0.00644	CcSEcCtD
Goserelin—Menopausal symptoms—Temozolomide—malignant glioma	0.00459	0.00641	CcSEcCtD
Goserelin—Thirst—Temozolomide—malignant glioma	0.00455	0.00635	CcSEcCtD
Goserelin—Affect lability—Temozolomide—malignant glioma	0.00426	0.00595	CcSEcCtD
Goserelin—LHCGR—Arf6 signaling events—EGFR—malignant glioma	0.00424	0.0179	CbGpPWpGaD
Goserelin—LHCGR—GPCRs, Class A Rhodopsin-like—CCR4—malignant glioma	0.00416	0.0176	CbGpPWpGaD
Goserelin—Mood swings—Temozolomide—malignant glioma	0.0041	0.00573	CcSEcCtD
Goserelin—Dry skin—Temozolomide—malignant glioma	0.00397	0.00554	CcSEcCtD
Goserelin—Breast disorder—Temozolomide—malignant glioma	0.00391	0.00546	CcSEcCtD
Goserelin—Bronchitis—Temozolomide—malignant glioma	0.0036	0.00503	CcSEcCtD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—CCR4—malignant glioma	0.00357	0.0151	CbGpPWpGaD
Goserelin—Dysuria—Temozolomide—malignant glioma	0.0035	0.00489	CcSEcCtD
Goserelin—Hyperglycaemia—Carmustine—malignant glioma	0.00349	0.00488	CcSEcCtD
Goserelin—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00348	0.00486	CcSEcCtD
Goserelin—Pneumonia—Carmustine—malignant glioma	0.00347	0.00485	CcSEcCtD
Goserelin—Pollakiuria—Temozolomide—malignant glioma	0.00346	0.00483	CcSEcCtD
Goserelin—Erectile dysfunction—Temozolomide—malignant glioma	0.00345	0.00481	CcSEcCtD
Goserelin—Depression—Carmustine—malignant glioma	0.00344	0.00481	CcSEcCtD
Goserelin—Photosensitivity reaction—Temozolomide—malignant glioma	0.00341	0.00477	CcSEcCtD
Goserelin—Weight increased—Temozolomide—malignant glioma	0.0034	0.00476	CcSEcCtD
Goserelin—Renal failure—Carmustine—malignant glioma	0.00339	0.00474	CcSEcCtD
Goserelin—Hyperglycaemia—Temozolomide—malignant glioma	0.00337	0.00471	CcSEcCtD
Goserelin—Urinary tract infection—Carmustine—malignant glioma	0.00335	0.00469	CcSEcCtD
Goserelin—Pneumonia—Temozolomide—malignant glioma	0.00335	0.00469	CcSEcCtD
Goserelin—Depression—Temozolomide—malignant glioma	0.00333	0.00465	CcSEcCtD
Goserelin—Urinary tract infection—Temozolomide—malignant glioma	0.00324	0.00453	CcSEcCtD
Goserelin—Sinusitis—Temozolomide—malignant glioma	0.00313	0.00437	CcSEcCtD
Goserelin—Haemoglobin—Carmustine—malignant glioma	0.00311	0.00435	CcSEcCtD
Goserelin—Haemorrhage—Carmustine—malignant glioma	0.0031	0.00433	CcSEcCtD
Goserelin—LHCGR—GPCRs, Class A Rhodopsin-like—CXCR3—malignant glioma	0.00309	0.0131	CbGpPWpGaD
Goserelin—Oedema peripheral—Carmustine—malignant glioma	0.00305	0.00426	CcSEcCtD
Goserelin—Haemoglobin—Temozolomide—malignant glioma	0.00301	0.0042	CcSEcCtD
Goserelin—Hepatitis—Temozolomide—malignant glioma	0.00299	0.00418	CcSEcCtD
Goserelin—Haemorrhage—Temozolomide—malignant glioma	0.00299	0.00418	CcSEcCtD
Goserelin—Pharyngitis—Temozolomide—malignant glioma	0.00297	0.00415	CcSEcCtD
Goserelin—Urinary tract disorder—Temozolomide—malignant glioma	0.00296	0.00413	CcSEcCtD
Goserelin—Oedema peripheral—Temozolomide—malignant glioma	0.00295	0.00412	CcSEcCtD
Goserelin—Urethral disorder—Temozolomide—malignant glioma	0.00294	0.0041	CcSEcCtD
Goserelin—Eye disorder—Carmustine—malignant glioma	0.0029	0.00404	CcSEcCtD
Goserelin—LHCGR—GPCRs, Class A Rhodopsin-like—BDKRB2—malignant glioma	0.00283	0.012	CbGpPWpGaD
Goserelin—Eye disorder—Temozolomide—malignant glioma	0.0028	0.00391	CcSEcCtD
Goserelin—Cardiac disorder—Temozolomide—malignant glioma	0.00278	0.00388	CcSEcCtD
Goserelin—Arrhythmia—Carmustine—malignant glioma	0.00277	0.00387	CcSEcCtD
Goserelin—Alopecia—Carmustine—malignant glioma	0.00274	0.00382	CcSEcCtD
Goserelin—LHCGR—GPCR ligand binding—CCR4—malignant glioma	0.00272	0.0115	CbGpPWpGaD
Goserelin—Angiopathy—Temozolomide—malignant glioma	0.00272	0.00379	CcSEcCtD
Goserelin—Mental disorder—Carmustine—malignant glioma	0.00271	0.00379	CcSEcCtD
Goserelin—Immune system disorder—Temozolomide—malignant glioma	0.0027	0.00378	CcSEcCtD
Goserelin—Erythema—Carmustine—malignant glioma	0.0027	0.00377	CcSEcCtD
Goserelin—Malnutrition—Carmustine—malignant glioma	0.0027	0.00377	CcSEcCtD
Goserelin—Chills—Temozolomide—malignant glioma	0.00269	0.00375	CcSEcCtD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—CXCR3—malignant glioma	0.00265	0.0112	CbGpPWpGaD
Goserelin—Alopecia—Temozolomide—malignant glioma	0.00265	0.0037	CcSEcCtD
Goserelin—Mental disorder—Temozolomide—malignant glioma	0.00262	0.00366	CcSEcCtD
Goserelin—Back pain—Carmustine—malignant glioma	0.00261	0.00364	CcSEcCtD
Goserelin—Malnutrition—Temozolomide—malignant glioma	0.00261	0.00364	CcSEcCtD
Goserelin—Erythema—Temozolomide—malignant glioma	0.00261	0.00364	CcSEcCtD
Goserelin—Vision blurred—Carmustine—malignant glioma	0.00254	0.00355	CcSEcCtD
Goserelin—Back pain—Temozolomide—malignant glioma	0.00252	0.00352	CcSEcCtD
Goserelin—Anaemia—Carmustine—malignant glioma	0.00249	0.00348	CcSEcCtD
Goserelin—Vision blurred—Temozolomide—malignant glioma	0.00246	0.00343	CcSEcCtD
Goserelin—GNRHR—G alpha (q) signalling events—BDKRB2—malignant glioma	0.00245	0.0104	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—BDKRB2—malignant glioma	0.00243	0.0103	CbGpPWpGaD
Goserelin—Ill-defined disorder—Temozolomide—malignant glioma	0.00242	0.00338	CcSEcCtD
Goserelin—Leukopenia—Carmustine—malignant glioma	0.00241	0.00337	CcSEcCtD
Goserelin—Anaemia—Temozolomide—malignant glioma	0.00241	0.00337	CcSEcCtD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCR4—malignant glioma	0.00239	0.0101	CbGpPWpGaD
Goserelin—Malaise—Temozolomide—malignant glioma	0.00235	0.00328	CcSEcCtD
Goserelin—Convulsion—Carmustine—malignant glioma	0.00234	0.00326	CcSEcCtD
Goserelin—Leukopenia—Temozolomide—malignant glioma	0.00233	0.00326	CcSEcCtD
Goserelin—Hypertension—Carmustine—malignant glioma	0.00233	0.00325	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—LATS2—malignant glioma	0.00232	0.00983	CbGpPWpGaD
Goserelin—Palpitations—Temozolomide—malignant glioma	0.0023	0.00322	CcSEcCtD
Goserelin—Chest pain—Carmustine—malignant glioma	0.0023	0.00321	CcSEcCtD
Goserelin—Myalgia—Carmustine—malignant glioma	0.0023	0.00321	CcSEcCtD
Goserelin—Anxiety—Carmustine—malignant glioma	0.00229	0.0032	CcSEcCtD
Goserelin—Cough—Temozolomide—malignant glioma	0.00227	0.00318	CcSEcCtD
Goserelin—Convulsion—Temozolomide—malignant glioma	0.00226	0.00315	CcSEcCtD
Goserelin—Hypertension—Temozolomide—malignant glioma	0.00225	0.00314	CcSEcCtD
Goserelin—GNRHR—G alpha (q) signalling events—KNG1—malignant glioma	0.00223	0.00944	CbGpPWpGaD
Goserelin—Confusional state—Carmustine—malignant glioma	0.00222	0.0031	CcSEcCtD
Goserelin—Myalgia—Temozolomide—malignant glioma	0.00222	0.0031	CcSEcCtD
Goserelin—Arthralgia—Temozolomide—malignant glioma	0.00222	0.0031	CcSEcCtD
Goserelin—Anxiety—Temozolomide—malignant glioma	0.00221	0.00309	CcSEcCtD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—KNG1—malignant glioma	0.00221	0.00934	CbGpPWpGaD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.0022	0.00308	CcSEcCtD
Goserelin—Oedema—Carmustine—malignant glioma	0.0022	0.00308	CcSEcCtD
Goserelin—Discomfort—Temozolomide—malignant glioma	0.00219	0.00306	CcSEcCtD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—BDKRB2—malignant glioma	0.00219	0.00929	CbGpPWpGaD
Goserelin—Infection—Carmustine—malignant glioma	0.00219	0.00305	CcSEcCtD
Goserelin—Dry mouth—Temozolomide—malignant glioma	0.00217	0.00303	CcSEcCtD
Goserelin—Thrombocytopenia—Carmustine—malignant glioma	0.00216	0.00301	CcSEcCtD
Goserelin—Tachycardia—Carmustine—malignant glioma	0.00215	0.003	CcSEcCtD
Goserelin—Confusional state—Temozolomide—malignant glioma	0.00214	0.003	CcSEcCtD
Goserelin—Anaphylactic shock—Temozolomide—malignant glioma	0.00213	0.00297	CcSEcCtD
Goserelin—Oedema—Temozolomide—malignant glioma	0.00213	0.00297	CcSEcCtD
Goserelin—Infection—Temozolomide—malignant glioma	0.00211	0.00295	CcSEcCtD
Goserelin—Anorexia—Carmustine—malignant glioma	0.0021	0.00293	CcSEcCtD
Goserelin—Nervous system disorder—Temozolomide—malignant glioma	0.00209	0.00291	CcSEcCtD
Goserelin—Thrombocytopenia—Temozolomide—malignant glioma	0.00208	0.00291	CcSEcCtD
Goserelin—Skin disorder—Temozolomide—malignant glioma	0.00207	0.00289	CcSEcCtD
Goserelin—Hypotension—Carmustine—malignant glioma	0.00206	0.00287	CcSEcCtD
Goserelin—Hyperhidrosis—Temozolomide—malignant glioma	0.00206	0.00287	CcSEcCtD
Goserelin—Anorexia—Temozolomide—malignant glioma	0.00203	0.00283	CcSEcCtD
Goserelin—LHCGR—GPCR ligand binding—CXCR3—malignant glioma	0.00202	0.00855	CbGpPWpGaD
Goserelin—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00201	0.0028	CcSEcCtD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—malignant glioma	0.00199	0.00845	CbGpPWpGaD
Goserelin—Insomnia—Carmustine—malignant glioma	0.00199	0.00278	CcSEcCtD
Goserelin—Paraesthesia—Carmustine—malignant glioma	0.00198	0.00276	CcSEcCtD
Goserelin—Dyspnoea—Carmustine—malignant glioma	0.00196	0.00274	CcSEcCtD
Goserelin—Somnolence—Carmustine—malignant glioma	0.00196	0.00273	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00194	0.00271	CcSEcCtD
Goserelin—Insomnia—Temozolomide—malignant glioma	0.00192	0.00269	CcSEcCtD
Goserelin—Decreased appetite—Carmustine—malignant glioma	0.00191	0.00267	CcSEcCtD
Goserelin—Paraesthesia—Temozolomide—malignant glioma	0.00191	0.00267	CcSEcCtD
Goserelin—Dyspnoea—Temozolomide—malignant glioma	0.0019	0.00265	CcSEcCtD
Goserelin—Somnolence—Temozolomide—malignant glioma	0.00189	0.00264	CcSEcCtD
Goserelin—Constipation—Carmustine—malignant glioma	0.00188	0.00263	CcSEcCtD
Goserelin—Pain—Carmustine—malignant glioma	0.00188	0.00263	CcSEcCtD
Goserelin—Dyspepsia—Temozolomide—malignant glioma	0.00187	0.00262	CcSEcCtD
Goserelin—Decreased appetite—Temozolomide—malignant glioma	0.00185	0.00258	CcSEcCtD
Goserelin—LHCGR—GPCR ligand binding—BDKRB2—malignant glioma	0.00185	0.00782	CbGpPWpGaD
Goserelin—Fatigue—Temozolomide—malignant glioma	0.00183	0.00256	CcSEcCtD
Goserelin—Pain—Temozolomide—malignant glioma	0.00182	0.00254	CcSEcCtD
Goserelin—Constipation—Temozolomide—malignant glioma	0.00182	0.00254	CcSEcCtD
Goserelin—GNRHR—GPCR ligand binding—CCR4—malignant glioma	0.00182	0.0077	CbGpPWpGaD
Goserelin—Feeling abnormal—Carmustine—malignant glioma	0.00181	0.00253	CcSEcCtD
Goserelin—Gastrointestinal pain—Carmustine—malignant glioma	0.0018	0.00251	CcSEcCtD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCR3—malignant glioma	0.00177	0.00752	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—malignant glioma	0.00177	0.00748	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—LATS1—malignant glioma	0.00176	0.00745	CbGpPWpGaD
Goserelin—Feeling abnormal—Temozolomide—malignant glioma	0.00175	0.00245	CcSEcCtD
Goserelin—Abdominal pain—Carmustine—malignant glioma	0.00174	0.00243	CcSEcCtD
Goserelin—Body temperature increased—Carmustine—malignant glioma	0.00174	0.00243	CcSEcCtD
Goserelin—Gastrointestinal pain—Temozolomide—malignant glioma	0.00174	0.00243	CcSEcCtD
Goserelin—Urticaria—Temozolomide—malignant glioma	0.00169	0.00236	CcSEcCtD
Goserelin—Abdominal pain—Temozolomide—malignant glioma	0.00168	0.00235	CcSEcCtD
Goserelin—Body temperature increased—Temozolomide—malignant glioma	0.00168	0.00235	CcSEcCtD
Goserelin—LHCGR—GPCR ligand binding—KNG1—malignant glioma	0.00168	0.00712	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—BDKRB2—malignant glioma	0.00162	0.00688	CbGpPWpGaD
Goserelin—Hypersensitivity—Carmustine—malignant glioma	0.00162	0.00227	CcSEcCtD
Goserelin—Asthenia—Carmustine—malignant glioma	0.00158	0.00221	CcSEcCtD
Goserelin—Hypersensitivity—Temozolomide—malignant glioma	0.00157	0.00219	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—LATS2—malignant glioma	0.00155	0.00658	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—CCR4—malignant glioma	0.00154	0.0065	CbGpPWpGaD
Goserelin—Asthenia—Temozolomide—malignant glioma	0.00153	0.00213	CcSEcCtD
Goserelin—Diarrhoea—Carmustine—malignant glioma	0.00151	0.0021	CcSEcCtD
Goserelin—Pruritus—Temozolomide—malignant glioma	0.0015	0.0021	CcSEcCtD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—KNG1—malignant glioma	0.00148	0.00626	CbGpPWpGaD
Goserelin—Dizziness—Carmustine—malignant glioma	0.00146	0.00203	CcSEcCtD
Goserelin—Diarrhoea—Temozolomide—malignant glioma	0.00146	0.00203	CcSEcCtD
Goserelin—GNRHR—G alpha (q) signalling events—F2—malignant glioma	0.00144	0.0061	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—F2—malignant glioma	0.00143	0.00604	CbGpPWpGaD
Goserelin—Dizziness—Temozolomide—malignant glioma	0.00141	0.00197	CcSEcCtD
Goserelin—Vomiting—Carmustine—malignant glioma	0.0014	0.00196	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—CCR4—malignant glioma	0.00139	0.0059	CbGpPWpGaD
Goserelin—Rash—Carmustine—malignant glioma	0.00139	0.00194	CcSEcCtD
Goserelin—Dermatitis—Carmustine—malignant glioma	0.00139	0.00194	CcSEcCtD
Goserelin—Headache—Carmustine—malignant glioma	0.00138	0.00193	CcSEcCtD
Goserelin—Vomiting—Temozolomide—malignant glioma	0.00135	0.00189	CcSEcCtD
Goserelin—GNRHR—GPCR ligand binding—CXCR3—malignant glioma	0.00135	0.00572	CbGpPWpGaD
Goserelin—Rash—Temozolomide—malignant glioma	0.00134	0.00187	CcSEcCtD
Goserelin—Dermatitis—Temozolomide—malignant glioma	0.00134	0.00187	CcSEcCtD
Goserelin—Headache—Temozolomide—malignant glioma	0.00133	0.00186	CcSEcCtD
Goserelin—Nausea—Carmustine—malignant glioma	0.00131	0.00183	CcSEcCtD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—F2—malignant glioma	0.00129	0.00546	CbGpPWpGaD
Goserelin—Nausea—Temozolomide—malignant glioma	0.00126	0.00177	CcSEcCtD
Goserelin—GNRHR—GPCR ligand binding—BDKRB2—malignant glioma	0.00124	0.00524	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—malignant glioma	0.00121	0.00513	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MDK—malignant glioma	0.00119	0.00503	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—LATS1—malignant glioma	0.00118	0.00499	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—CXCR3—malignant glioma	0.00114	0.00483	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—DTX1—malignant glioma	0.00113	0.0048	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—KNG1—malignant glioma	0.00112	0.00476	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—F2—malignant glioma	0.00109	0.0046	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—BDKRB2—malignant glioma	0.00104	0.00442	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CXCR3—malignant glioma	0.00104	0.00439	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CCR4—malignant glioma	0.00103	0.00435	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—CXCL8—malignant glioma	0.001	0.00426	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—malignant glioma	0.000968	0.0041	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—F2—malignant glioma	0.000955	0.00404	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—KNG1—malignant glioma	0.000949	0.00402	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—BDKRB2—malignant glioma	0.000948	0.00401	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CCR4—malignant glioma	0.000933	0.00395	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—SUFU—malignant glioma	0.0009	0.00381	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—HEY2—malignant glioma	0.000889	0.00377	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—GFAP—malignant glioma	0.000869	0.00368	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—KNG1—malignant glioma	0.000862	0.00365	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—SPHK1—malignant glioma	0.000841	0.00356	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—HEY1—malignant glioma	0.000824	0.00349	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CCR4—malignant glioma	0.000824	0.00349	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—HIST1H3B—malignant glioma	0.0008	0.00339	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MDK—malignant glioma	0.000795	0.00337	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—CXCL8—malignant glioma	0.000765	0.00324	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—MMP3—malignant glioma	0.000764	0.00324	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CXCR3—malignant glioma	0.000764	0.00324	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—DTX1—malignant glioma	0.000759	0.00321	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—JAG2—malignant glioma	0.00073	0.00309	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—F2—malignant glioma	0.000727	0.00308	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—BDKRB2—malignant glioma	0.000699	0.00296	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CXCR3—malignant glioma	0.000694	0.00294	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCL8—malignant glioma	0.000673	0.00285	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—malignant glioma	0.000664	0.00281	CbGpPWpGaD
Goserelin—GNRHR—G alpha (q) signalling events—PIK3CA—malignant glioma	0.000644	0.00273	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—KNG1—malignant glioma	0.000636	0.00269	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—BDKRB2—malignant glioma	0.000634	0.00269	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—malignant glioma	0.000627	0.00266	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—H3F3A—malignant glioma	0.000618	0.00262	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—F2—malignant glioma	0.000614	0.0026	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CXCR3—malignant glioma	0.000612	0.00259	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—SUFU—malignant glioma	0.000603	0.00255	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—YWHAE—malignant glioma	0.000595	0.00252	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—NTRK2—malignant glioma	0.000595	0.00252	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—HEY2—malignant glioma	0.000595	0.00252	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—FLT1—malignant glioma	0.000593	0.00251	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—DUSP6—malignant glioma	0.00059	0.0025	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—PIK3CG—malignant glioma	0.000587	0.00249	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—JAG1—malignant glioma	0.000583	0.00247	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—GFAP—malignant glioma	0.000582	0.00246	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—NOTCH3—malignant glioma	0.00058	0.00246	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—KNG1—malignant glioma	0.000577	0.00244	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—malignant glioma	0.000576	0.00244	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—FBXW7—malignant glioma	0.000571	0.00242	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—SPHK1—malignant glioma	0.000563	0.00238	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—BDKRB2—malignant glioma	0.00056	0.00237	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—F2—malignant glioma	0.000557	0.00236	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—HEY1—malignant glioma	0.000551	0.00234	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CCR4—malignant glioma	0.000551	0.00234	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—AKT2—malignant glioma	0.000537	0.00228	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—HIST1H3B—malignant glioma	0.000536	0.00227	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—PIK3CG—malignant glioma	0.000533	0.00226	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—PTPN11—malignant glioma	0.000524	0.00222	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—NOTCH2—malignant glioma	0.00052	0.0022	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—PIK3CD—malignant glioma	0.000516	0.00219	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CXCL8—malignant glioma	0.000512	0.00217	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—MMP3—malignant glioma	0.000511	0.00217	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—KNG1—malignant glioma	0.000509	0.00216	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—JAG2—malignant glioma	0.000489	0.00207	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—AKT2—malignant glioma	0.000488	0.00207	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—NTRK1—malignant glioma	0.000485	0.00206	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—PIK3CD—malignant glioma	0.000469	0.00199	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MMP3—malignant glioma	0.000451	0.00191	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—PIK3CB—malignant glioma	0.00045	0.00191	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CDKN2B—malignant glioma	0.000447	0.00189	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PTK2—malignant glioma	0.000434	0.00184	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—CXCL8—malignant glioma	0.000432	0.00183	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—HES1—malignant glioma	0.000427	0.00181	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—NCOR1—malignant glioma	0.000424	0.0018	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—RAF1—malignant glioma	0.000419	0.00177	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—H3F3A—malignant glioma	0.000414	0.00175	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—IL2—malignant glioma	0.000413	0.00175	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—F2—malignant glioma	0.000411	0.00174	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CXCR3—malignant glioma	0.00041	0.00174	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—PIK3CB—malignant glioma	0.000409	0.00173	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PDGFRA—malignant glioma	0.000406	0.00172	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—YWHAE—malignant glioma	0.000399	0.00169	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—NTRK2—malignant glioma	0.000399	0.00169	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—FLT1—malignant glioma	0.000397	0.00168	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—DUSP6—malignant glioma	0.000395	0.00167	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—SPP1—malignant glioma	0.000394	0.00167	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—PIK3CG—malignant glioma	0.000393	0.00167	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CXCL8—malignant glioma	0.000393	0.00166	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—JAG1—malignant glioma	0.00039	0.00165	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—NOTCH3—malignant glioma	0.000388	0.00165	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—FBXW7—malignant glioma	0.000382	0.00162	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—IL2—malignant glioma	0.000375	0.00159	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—BDKRB2—malignant glioma	0.000375	0.00159	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—TERT—malignant glioma	0.000374	0.00158	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—F2—malignant glioma	0.000373	0.00158	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PDGFB—malignant glioma	0.000365	0.00155	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—FGFR1—malignant glioma	0.000363	0.00154	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—AKT2—malignant glioma	0.00036	0.00152	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—HIF1A—malignant glioma	0.000358	0.00151	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—PIK3CG—malignant glioma	0.000357	0.00151	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—PTPN11—malignant glioma	0.000351	0.00149	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—NOTCH2—malignant glioma	0.000348	0.00148	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CAV1—malignant glioma	0.000346	0.00146	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—PIK3CD—malignant glioma	0.000346	0.00146	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—KDR—malignant glioma	0.000342	0.00145	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—KNG1—malignant glioma	0.000341	0.00144	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—F2—malignant glioma	0.000329	0.00139	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—FN1—malignant glioma	0.000329	0.00139	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—AKT2—malignant glioma	0.000327	0.00138	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—BAD—malignant glioma	0.000325	0.00138	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—NTRK1—malignant glioma	0.000325	0.00138	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—NOTCH1—malignant glioma	0.000322	0.00136	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CD80—malignant glioma	0.000316	0.00134	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—APC—malignant glioma	0.000315	0.00133	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PIK3CG—malignant glioma	0.000315	0.00133	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—PIK3CD—malignant glioma	0.000314	0.00133	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—EGF—malignant glioma	0.000311	0.00132	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PTPN11—malignant glioma	0.00031	0.00131	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MMP3—malignant glioma	0.000302	0.00128	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—PIK3CB—malignant glioma	0.000301	0.00128	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CDKN2B—malignant glioma	0.000299	0.00127	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—BRAF—malignant glioma	0.000296	0.00125	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PTK2—malignant glioma	0.000291	0.00123	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CXCL8—malignant glioma	0.000289	0.00123	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—AKT2—malignant glioma	0.000288	0.00122	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—EGFR—malignant glioma	0.000287	0.00122	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—HES1—malignant glioma	0.000286	0.00121	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—NCOR1—malignant glioma	0.000284	0.0012	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—RAF1—malignant glioma	0.00028	0.00119	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PIK3CD—malignant glioma	0.000277	0.00117	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—IL2—malignant glioma	0.000277	0.00117	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—PIK3CA—malignant glioma	0.000274	0.00116	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—PIK3CB—malignant glioma	0.000274	0.00116	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PDGFRA—malignant glioma	0.000272	0.00115	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—KRAS—malignant glioma	0.000271	0.00115	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—FGF2—malignant glioma	0.000265	0.00112	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—SPP1—malignant glioma	0.000264	0.00112	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CXCL8—malignant glioma	0.000263	0.00111	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—IL2—malignant glioma	0.000251	0.00106	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—TERT—malignant glioma	0.00025	0.00106	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—PIK3CA—malignant glioma	0.000249	0.00106	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MDM2—malignant glioma	0.000248	0.00105	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—RAF1—malignant glioma	0.000247	0.00105	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—ERBB2—malignant glioma	0.000245	0.00104	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PDGFB—malignant glioma	0.000244	0.00103	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—FGFR1—malignant glioma	0.000243	0.00103	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PIK3CB—malignant glioma	0.000241	0.00102	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—HIF1A—malignant glioma	0.000239	0.00101	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CXCL8—malignant glioma	0.000232	0.000982	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CAV1—malignant glioma	0.000232	0.000981	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—KDR—malignant glioma	0.000229	0.00097	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—AKT1—malignant glioma	0.000224	0.000949	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CASP3—malignant glioma	0.000222	0.00094	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—IL2—malignant glioma	0.000222	0.000939	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—F2—malignant glioma	0.00022	0.000933	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—FN1—malignant glioma	0.00022	0.000933	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—BAD—malignant glioma	0.000218	0.000922	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—NOTCH1—malignant glioma	0.000216	0.000913	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CD80—malignant glioma	0.000211	0.000895	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—APC—malignant glioma	0.000211	0.000893	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PIK3CG—malignant glioma	0.000211	0.000893	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MMP9—malignant glioma	0.00021	0.000889	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PTEN—malignant glioma	0.000209	0.000883	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—EGF—malignant glioma	0.000208	0.000883	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PTPN11—malignant glioma	0.000207	0.000878	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—AKT1—malignant glioma	0.000204	0.000862	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—BRAF—malignant glioma	0.000198	0.00084	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—AKT2—malignant glioma	0.000193	0.000817	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—EGFR—malignant glioma	0.000192	0.000814	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—VEGFA—malignant glioma	0.000188	0.000798	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—STAT3—malignant glioma	0.000187	0.00079	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PIK3CD—malignant glioma	0.000185	0.000785	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—PIK3CA—malignant glioma	0.000184	0.000778	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—KRAS—malignant glioma	0.000182	0.000769	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—FGF2—malignant glioma	0.000178	0.000752	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MYC—malignant glioma	0.000173	0.000734	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—EGFR—malignant glioma	0.00017	0.000718	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—PIK3CA—malignant glioma	0.000167	0.000706	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MDM2—malignant glioma	0.000166	0.000703	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—RAF1—malignant glioma	0.000166	0.000701	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—ERBB2—malignant glioma	0.000164	0.000694	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PIK3CB—malignant glioma	0.000162	0.000684	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—KRAS—malignant glioma	0.00016	0.000678	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CXCL8—malignant glioma	0.000155	0.000658	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—AKT1—malignant glioma	0.00015	0.000635	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CASP3—malignant glioma	0.000149	0.00063	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IL2—malignant glioma	0.000148	0.000629	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PIK3CA—malignant glioma	0.000147	0.000623	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—TP53—malignant glioma	0.000142	0.000603	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MMP9—malignant glioma	0.00014	0.000595	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PTEN—malignant glioma	0.00014	0.000591	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—AKT1—malignant glioma	0.000136	0.000577	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—VEGFA—malignant glioma	0.000126	0.000534	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—STAT3—malignant glioma	0.000125	0.000529	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—AKT1—malignant glioma	0.00012	0.000509	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MYC—malignant glioma	0.000116	0.000491	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—EGFR—malignant glioma	0.000114	0.000481	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—KRAS—malignant glioma	0.000107	0.000454	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PIK3CA—malignant glioma	9.85e-05	0.000417	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—TP53—malignant glioma	9.53e-05	0.000404	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—AKT1—malignant glioma	8.05e-05	0.000341	CbGpPWpGaD
